The Division of Oncology’'s administrative offices, research laboratories, and research faculty are housed in The Center for Clinical Sciences Research (CCSR). State-of-the-art laboratories and core facilities reflect the private philanthropic commitments of more than $77 million which provided funding for the project. The most advanced research facilities and equipment enable researchers to produce and safety-test materials to be administered to patients in human clinical trials and to analyze cells from patients to monitor the effects of treatment in real time.

By its physical layout, the CCSR, completed in May, 2000, integrates scientists from several departments around three major interdisciplinary, interdepartmental programs - cancer biology and cancer therapy, immunology and transplantation, and genetics and gene therapy - creating the critical mass of new ideas that is essential to scientific advancement.

The Center for Clinical Sciences Research houses four major investigative centers:

• The Center for Cancer Research includes distinguished scientists from multiple disciplines and forms the anchor program for the new building.
• The Center for Clinical Immunology pursues applications of immunological research in the treatment of diseases as diverse as juvenile-onset diabetes, rheumatoid arthritis, asthma, multiple sclerosis, systematic lupus erythematusus, acquired immune deficiency syndrome, and many cancers.
• The Center for Applied Human Genetics focuses on developing genetic therapies that will reach across the spectrum of human diseases from single-gene disorders to genetically complex systemic diseases such as atherosclerosis and cancer.
• The Department of Molecular Pharmacology studies the basic mechanisms of a variety of diseases and the therapeutic uses of drugs.